Mitraclip Secondary Mr denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for mitraclip secondary mr are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied MitraClip for Secondary Mitral Regurgitation as Non-Formulary

For a device-based procedure like MitraClip, a non-formulary denial is functionally a coverage-tier issue: BCBS's benefit structure does not include transcatheter edge-to-edge repair (TEER) as a covered benefit under standard plan terms, or the procedure falls outside the contracted network of facilities approved to perform it under your plan. This framing is distinct from a drug formulary exclusion, but the appeal rights are identical.

## Why This Denial Is Appealable

Even when a service is classified as non-formulary or not listed as a standard benefit, you retain the right to appeal on two grounds. First, if BCBS covers cardiac surgical alternatives for mitral regurgitation (such as open mitral valve repair or replacement), a non-formulary exclusion of a less invasive FDA-approved alternative with comparable clinical goals can be challenged as inconsistent plan administration — particularly if your plan is subject to ACA parity rules or your state's coverage mandates. Second, if BCBS does cover TEER in other clinical scenarios (e.g., primary MR), the exclusion of the secondary MR indication may be appealable as an arbitrary distinction.

## Federal Appeal Framework

• Internal appeal: File within the plan's deadline (typically 180 days from the denial notice). Decisions are due within 30 days (pre-service) or 60 days (post-service).
• External review (ACA §2719 / ERISA §503): Non-formulary or coverage-tier denials are reviewable externally if they involve a medical judgment. Request external review within approximately four months of the final internal denial.
• Expedited review: Available when delay threatens your health; typically resolved within 72 hours.
• State insurance commissioner: If your plan is a fully-insured state-regulated plan (not self-funded ERISA), your state's insurance department may have additional coverage-mandate authority.

## Documentation to Gather

1. Plan benefit documents: Request your Summary Plan Description (SPD) and the specific benefit language for structural heart procedures and cardiac surgery — identify what is and is not covered. 2. FDA labeling: The MitraClip Instructions for Use confirming the FDA-approved secondary MR indication. 3. Comparator coverage evidence: If BCBS covers open mitral valve surgery for equivalent patients, note that in your appeal as evidence of inconsistent exclusion. 4. Prescriber letter: A letter from your structural cardiologist explaining why MitraClip is the clinically appropriate choice for your anatomy and risk profile, and why covered surgical alternatives are not equivalently suitable. 5. Heart team note: Multidisciplinary assessment documenting surgical risk that supports preference for the transcatheter approach.

## Criteria-Mapping Structure

Obtain BCBS's medical policy and your plan's benefit schedule. For the appeal letter:

| Issue | Your Position | Supporting Document | |---|---|---| | Is TEER categorically excluded? | No — FDA-approved for secondary MR | FDA labeling | | Are surgical alternatives covered? | Yes — establishes plan covers MR treatment | Benefit schedule | | Is TEER clinically distinct from surgery? | Yes for your anatomy/risk profile | Heart team note | | Non-formulary exception process followed? | Yes — formal exception requested | Appeal submission record |

If your plan offers a formulary or coverage exception process, invoke it explicitly in your appeal alongside the standard appeal rights.